Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types

BACKGROUND: In the Response Evaluation Criteria for Solid Tumors (RECIST) diagnostic criteria, the concepts of progression by preexisting disease (PPL) and progression by new metastases (PNM) have been proposed to distinguish between the progression types of cancer refractory to treatment. According...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisaki, Tamami, Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Takada, Koji, Ishihara, Sae, Shibutani, Masatsune, Tanaka, Hiroaki, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591927/
https://www.ncbi.nlm.nih.gov/pubmed/34775950
http://dx.doi.org/10.1186/s12957-021-02441-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591927/
https://www.ncbi.nlm.nih.gov/pubmed/34775950
http://dx.doi.org/10.1186/s12957-021-02441-w

Ejemplares similares